SCHEMBL16205349

SCHEMBL16205349

CC(=O)c1c[nH]c2c(C)nc(Cl)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRPF1 P55201 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HASPIN Q8TF76 1/20 0.40
▸ PBRM1 Q86U86 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ AHR P35869 1/20 0.36
▸ CSNK2A2 P19784 3/20 0.36
▸ CSNK2B P67870 3/20 0.36
▸ CSNK2A1 P68400 3/20 0.36
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KMO O15229 1/20 0.35
▸ NR4A2 P43354 2/20 0.34
▸ GAA P10253 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20487884 0.86 BRPF1 (0.46) BRPF1SMN1; SMN2HASPINPBRM1HSD17B10
SCHEMBL19644386 0.83 NR4A2 (0.54) SMN1; SMN2HSD17B10KDM4EALDH1A1TP53
SCHEMBL21024318 0.83 ALDH1A1 (0.35) BRPF1CSNK2A2CSNK2BCSNK2A1ALDH1A1
SCHEMBL4301614 0.80 CSNK2A1 (0.56) HSD17B10KDM4ECSNK2A2CSNK2BCSNK2A1
SCHEMBL21752200 0.78 BRPF1 (0.37) BRPF1HASPINPBRM1HSD17B10KDM4E
SCHEMBL16205508 0.78 MAPT (0.44) SMN1; SMN2KDM4EKMT2AMEN1ALDH1A1
SCHEMBL19657598 0.77 NR4A2 (0.35) SMN1; SMN2KDM4ENR4A2
SCHEMBL19657777 0.76 — —
SCHEMBL4300488 0.75 CYP1A2 (0.63) HSD17B10KDM4EKMT2AMEN1ALDH1A1
SCHEMBL22822744 0.70 LMNA (0.30) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643964-B2 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer JANSSEN PHARMACEUTICA NV (BE) 2017-05-09 — — US disclosed
WO-2014174021-A1 3-(2-AMINOPYRIMIDIN-4-YL)-5-(3-HYDROXYPROPYNYL)-1H-PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS NIK INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2014-10-30 — — WO disclosed
Send feedback